- Home
- ITRG vs FDMT Comparison
ITRG vs FDMT Comparison
Compare ITRG & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITRG | FDMT |
|---|---|---|
| Founded | 1997 | 2013 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 482.5M | 455.4M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | ITRG | FDMT |
|---|---|---|
| Price | $3.92 | $7.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $4.13 | ★ $30.33 |
| AVG Volume (30 Days) | ★ 1.9M | 1.2M |
| Earning Date | 11-12-2025 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $219,125,000.00 | $120,000.00 |
| Revenue This Year | $965.93 | $21,181.08 |
| Revenue Next Year | $9.39 | $162.43 |
| P/E Ratio | $54.65 | ★ N/A |
| Revenue Growth | N/A | ★ 605.88 |
| 52 Week Low | $0.79 | $2.24 |
| 52 Week High | $4.69 | $12.34 |
Technical Indicators
Market Signals| Indicator | ITRG | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 49.54 | 37.25 |
| Support Level | $3.73 | $7.20 |
| Resistance Level | $4.10 | $8.06 |
| Average True Range (ATR) | 0.23 | 0.46 |
| MACD | -0.08 | -0.04 |
| Stochastic Oscillator | 21.50 | 26.44 |
Price Performance
Historical ComparisonAbout ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.